Dear Mathilde de Jeu,

EFSA hereby acknowledges receipt of your application for public access to documents (PAD). Your PAD application has been registered and will be processed in accordance with Regulation (EC) No 1049/2001 (the “PAD Regulation”). We will revert to you within 15 working days from the date of registration of your PAD application.

PAD Application Summary
PAD Number: 00014143
Contact Name:
Subject: "Access to Documents Request Regarding GLP-1 Medications"
Request: "

show quoted sections

[1]Efsa Logo                                                             
                                                                         
                                                                         
       

══════════════════════════════════════════════════════════════════════════
Dear Ms de Jeu,

I hereby acknowledge receipt of your e-mail of 27 November 2024, by means
of which you requested access to:

“Documents related to lobbying activities concerning GLP-1 medications.
Specifically, I seek information involving large processed food
manufacturers, including but not limited to Nestlé, Unilever, and similar
companies. As a journalist investigating corporate influence on health
regulations, I request access to the following:

Correspondence:
Emails, letters, or other forms of communication exchanged between
representatives of processed food manufacturers (such as Nestlé and
Unilever), their affiliates, or lobby organizations (e.g., the European
Food Information Council (EUFIC)) and EFSA officials. This should cover
discussions on GLP-1 medications’ impact on public health, food
consumption, or regulatory assessments related to health claims or
integration with food products.
Meetings:
Minutes, notes, or summaries of meetings with representatives of processed
food companies or their lobby organizations discussing:
Potential impacts of GLP-1 medications on consumer behavior and processed
food markets.
Lobbying efforts or opinions expressed regarding regulations for GLP-1
drugs, especially those used in weight management.
Integration of GLP-1 drugs within food products or related health claims.
Documents:
Internal reports, analyses, or memos referring to lobbying efforts by
processed food companies to influence EFSA's stance on GLP-1 medications.
This includes any documented concerns about market impacts, regulatory
guidelines, or public health considerations.

Consultations:
Records of consultations with processed food industry representatives
concerning GLP-1 regulation or health claims affecting food products.
Timeframe: 2020 to the present.”

In addition you highlight that:

“My inquiry aims to examine the influence of processed food companies on
EFSA’s regulatory processes concerning GLP-1 medications.

If any part of the requested documentation is subject to exemptions under
Regulation (EC) No 1049/2001, please provide detailed reasons for any
redactions or withholdings. I also request a list of all existing
documents, including those withheld.”

Your application for public access to documents (PAD) has been registered
as PAD 2024/183 (00014143) and is being processed as quickly as possible
in accordance with [2]Regulation (EC) No 1049/2001 regarding public access
to documents (hereinafter “the PAD Regulation”).

We will come back to you by 18 December 2024 at the latest.

We would like to inform you that the AsktheEU.org website you have used
for submitting your request is a third-party platform, with no link to the
institutions, agencies and bodies of the EU, including EFSA. Consequently,
EFSA cannot be held liable for any errors of any kind occurring as a
result of the use of this platform. Likewise, we would ask you to provide
us with an alternative e-mail address to be used for the further
processing of your application for access to documents.

Additionally, please note that the third party running the AsktheEU.org
website is responsible for the processing of your personal data by means
of this platform. For further information, including on the way the third
party addresses your rights in the light of applicable data protection
legislation, please refer to the third party’s privacy policy. From our
experience with the way the platform operates, we understand that the
content of public access to documents requesters correspondence with EFSA
is usually published on the platform, including any personal data which
may be contained therein (e.g. private postal addresses). Please contact
us directly should you not wish your correspondence with EFSA to be
published on the AsktheEU.org platform. In the event that such a
communication is received from you, EFSA will then redirect all future
electronic correspondence to your private e-mail address only.

Please also be aware that Article 16 of the PAD Regulation regarding
public access to documents provides that this legal framework is
applicable without prejudice to any existing rules on copyright which may
limit a third party's right to reproduce or exploit released documents.

Finally, note that EFSA is using an online tool for processing public
access to documents application which can be accessed via the
[3]Connect.EFSA platform (“The PAD Tool”). In order to ensure a thorough
monitoring of PAD applications being processed by EFSA, your PAD
application has been included in this PAD tool. For this purpose, we ask
you to communicate to us your private e-mail address, so that future
communications with you can be sent via the PAD Tool. Should you be
interested in using it for eventual future PAD applications, we highly
recommend that you register in the system to better follow the processing
of your PAD applications and other queries you may submit to EFSA. Should
you wish to submit a new PAD application, please select “public access to
documents” in the ‘area’ box of the online form.

Yours sincerely,

Mariama MESNAOUI
Technical Assistant
EFSA Public Access to Documents
 
For replying to this e-mail, please make sure you press “Reply” from your
e-mail management tool (Outlook, Gmail, etc)

Please make sure you copy the EFSA
mailbox [4][email address] in all your
communications with EFSA.

[5]image001
 
 
 
 

Public Access to Documents
Legal Affairs Services
[6][email address]
[7]www.efsa.europa.eu

[8]twitter[9]linkedin[10]youtube[11]instagram

This e-mail and its attachments is intended for the recipient(s) named in
the message. If you are not an intended recipient, please let the sender
know immediately. Any disclosure or copying of the message content is
unauthorised and may be unlawful if you are not the intended recipient.

References

Visible links
2. https://eur03.safelinks.protection.outlo...
3. https://eur03.safelinks.protection.outlo...
4. mailto:[email address]
6. mailto:[email address]
7. https://www.efsa.europa.eu/
8. twitter
https://twitter.com/EFSA_EU
9. linkedin
https://it.linkedin.com/company/efsa
10. youtube
https://www.youtube.com/user/EFSAchannel
11. instagram
https://www.instagram.com/one_healthenv_...

[1]Efsa Logo                                                             
                                                                         
                                                                         
       

══════════════════════════════════════════════════════════════════════════
Dear Ms de Jeu, 

Please find the letter of reply referenced 33216300 from Ms Luisa Venier
for EFSA Public Access to Documents at the following link:

[2]?pdf icon[3] EFSA Ref. out 33216300_PAD 2024_183 (00014143) Reply.pdf

I wish you a good reception of this letter.

Yours sincerely,

Alessandra Di Nunzio
Legal Officer
EFSA Public Access to Documents
Legal Affairs Services
For replying to this e-mail, please make sure you press “Reply” from your
e-mail management tool (Outlook, Gmail, etc)

Please make sure you copy the EFSA
mailbox [4][email address] in all your
communications with EFSA.

[5]image001
 
 
 
 

Public Access to Documents
Legal Affairs Services
[6][email address]
[7]www.efsa.europa.eu

[8]twitter[9]linkedin[10]youtube[11]instagram

This e-mail and its attachments is intended for the recipient(s) named in
the message. If you are not an intended recipient, please let the sender
know immediately. Any disclosure or copying of the message content is
unauthorised and may be unlawful if you are not the intended recipient.

References

Visible links
2. https://efsa815-my.sharepoint.com/:b:/g/...
3. https://efsa815-my.sharepoint.com/:b:/g/...
4. mailto:[email address]
6. mailto:[email address]
7. https://www.efsa.europa.eu/
8. twitter
https://twitter.com/EFSA_EU
9. linkedin
https://it.linkedin.com/company/efsa
10. youtube
https://www.youtube.com/user/EFSAchannel
11. instagram
https://www.instagram.com/one_healthenv_...

Dear sender, If you want to answer an e-mail originating from EFSA sent
via Connect.EFSA tool, kindly make sure you press the “Reply” button. If
you select “new e-mail” or you use “forward” instead, your e-mail will be
will not be able to track it and it will be deleted by the system. Yours
sincerely, EFSA

[1]Efsa Logo                                                             
                                                                         
                                                                         
       

══════════════════════════════════════════════════════════════════════════
Dear Ms de Jeu, 

I thank you for your message. I understand from your feedback that you
encountered difficulties to access the link sent to you on 18/12/2024.
Please accept my apologies for the inconvenience caused by this technical
issue.
As requested, please find here the newly created link to the letter of
reply referenced 33216300 from Ms Luisa Venier for EFSA Public Access to
Documents as well as in attachment to this message as an alternative.  

[2]?pdf icon[3] EFSA Ref. out 33216300_PAD 2024_183 (00014143) Reply.pdf

I wish you a good reception of this letter.

Yours sincerely,

Mariama MESNAOUI
Technical Assistant
EFSA Public Access to Documents
 
For replying to this e-mail, please make sure you press “Reply” from your
e-mail management tool (Outlook, Gmail, etc)

Please make sure you copy the EFSA
mailbox [4][email address] in all your
communications with EFSA.

[5]image001
 
 
 
 

Public Access to Documents
Legal Affairs Services
[6][email address]
[7]www.efsa.europa.eu

[8]twitter[9]linkedin[10]youtube[11]instagram

This e-mail and its attachments is intended for the recipient(s) named in
the message. If you are not an intended recipient, please let the sender
know immediately. Any disclosure or copying of the message content is
unauthorised and may be unlawful if you are not the intended recipient.

--------------- Original Message

show quoted sections